CyMon Bio
Agoura Hills, US · Founded 2023 · Delaware corporation
Founders & leadership
TH
Thomas H Bliss, Jr.Named on SEC filing
KG
Keith GreenfieldNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$921.8K disclosed across 1 round · 2024
▶$921.8KraisedFeb 2024 · 9 investors · Other TechnologyRule 506(b)
▶$921.8KraisedFeb 2024 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas H Bliss, Jr.Executive Officer, Director
- Keith GreenfieldExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $921.8K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CyMon Bio raised?
- CyMon Bio has disclosed $921.8K raised across 1 round.
- Where is CyMon Bio headquartered?
- CyMon Bio is headquartered in Agoura Hills, US.